Prakt. Lékáren. 2016; 12(2e): e19-e22

Diabetic patient in community pharmacy – can we solve his problems?

PharmDr. Aleš Mareček
Lékárna U Orla, Liberec
Herz-Apotheke, Zittau (DE)

There are many barriers in the community pharmacy that hinder identifying of drug-related problem, e. g. lack of informations aboutpatient or lack of time. In the presented case report it was possible to identify the reason for poor diabetes control through appropriatecommunication with the patient during dispensing drugs.

Keywords: community pharmacy, management of drug-related problems, hypoglycemia, drug dosing, case report

Published: May 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mareček A. Diabetic patient in community pharmacy – can we solve his problems? Praktické lékárenství. 2016;12(E-verze 2/16):e19-22.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hojný M, Zajícová M, Vlček J, Bažantová M. Doporučený postup pro výdej léčivých přípravků na lékařský předpis. Česká lékárnická komora, 2015, http://www.lekarnici.cz/getattachment/Vzdelavani/Doporucene-postupy/DP-PRO-VYDEJ-LECIVYCH-PRIPRAVKU-VAZANYCH-NA-LEKARSKY-PREDPIS-2015-08-16.pdf.aspx [cit. 2015-11-30].
    2. Malý J, Opavová T, Vlček J. Bariéry a možnosti dalšího rozvoje konzultační činnosti v lékárnách v České republice. Prakt. lékáren. 2012; 8(1): 31-33.
    3. Tilšer I. Diabetes mellitus. In: Vlček J, Fialová D, et al. Klinická farmacie I. Grada 2010: 187-206.
    4. Šmahelová A, Lášticová M. Diabetologie pro farmaceuty. Mladá fronta 2011: s. 39.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.